Moderna (NASDAQ:MRNA) was among the notable gainers on Wednesday after Oracle (NYSE:ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of messenger RNA-based cancer ...

Ellison claimed using AI, a messenger RNA-based vaccine could be produced robotically in just 48 hours. Moderna is using its mRNA technology to develop a cancer vaccine in partnership with Merck. ...

Oracle Chairman Larry Ellison highlighted the potential medical benefits of the investment, stating that AI could be used to detect cancers and customize mRNA vaccines to treat them within 48 hours.

In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of Replicate Bioscience and Alliance for mRNA Medicines, and Pad Chivukula of ...

Stargate AI project could help create cancer mRNA vaccine, Oracle CEO Larry Ellison says. President Donald Trump says project will create more than 100,000 American jobs.

Oracle founder Larry Ellison said the massive artificial intelligence (AI) infrastructure project dubbed Stargate is helping to fuel the development of a cancer vaccine. President Donald Trump ...

"Imagine early cancer detection, the development of a cancer vaccine for your particular cancer aimed at you, and have that vaccine available in 48 hours," Oracle co-founder Larry Ellison said at ...

That mRNA vaccine, you can make that robotically, again using AI, in about 48 hours,” said Ellison. “So imagine, early cancer detection, the development of a cancer vaccine for your particular ...

Moderna (MRNA) stock gained after Oracle (ORCL) Chairman Larry Ellison highlighted the AI's potential in the development of mRNA-based cancer vaccines. Read more here.

"Imagine early cancer detection, the development of a cancer vaccine for your particular cancer aimed at you, and have that vaccine available in 48 hours," Oracle co-founder Larry Ellison said at ...